Arbutus Biopharma Corporation (ABUS) slipped -5.58% or -0.13 to $2.2. It is near to 86837 shares traded, which is 22.23% compare to the average total volume 390560. The market cap of ABUS is $127.63 million. The year to date change is -47.33%. The 52 week price range is from $2.18 to $12.6. Price of ABUS have changed -2.10% during last week. It have changed -26.03% over last month, -37.87% over last 3 months, -50.21% over last 6 months and -59.83% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 3.25. It is 47.73% above current price. The 200-day Moving Averages for ABUS is 5.26. It is 139.09% above current price. The 52-week High is 12.6. It is 472.73% from the current price. The 52-week Low is 2.18. It is -0.91% from current price.
There are some statistics of ABUS. It is has market cap $127.63 million. The share outstanding is 58.01 million. The average volume is 390560. The percent of top 15 Institution holding is 49.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -93.90%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -32.23%.